RBM4 and colorectal carcinoma: Another study highlighted the potential value of targeting this splicing cascade for CRC treatment and demonstrated how cell migration and angiogenesis are increased via RBM4-regulated isoform expression of Nova1 (exon 4 skipping), SRSF6 (intron 2 retention), and VEGF165 upregulation.